QINECSA SOLUTIONS UK OPCO LIMITED

Active London

Activities of financial services holding companies

21 employees website.com
Life sciences and medical technology Activities of financial services holding companies
Q

QINECSA SOLUTIONS UK OPCO LIMITED

Activities of financial services holding companies

Founded 15 Feb 2022 Active London, United Kingdom 21 employees website.com
Life sciences and medical technology Activities of financial services holding companies

Previous Company Names

HUMMINGBIRD UK OPCO LIMITED 15 Feb 2022 — 29 Jul 2022
Accounts Submitted 20 Mar 2026 Next due 29 Dec 2025 6 months overdue
Confirmation Submitted 16 Mar 2026 Next due 1 Mar 2027 8 months remaining
Net assets £-34M £29M 2024 year on year
Total assets £914K £4M 2024 year on year
Total Liabilities £34M £25M 2024 year on year
Charges 4
4 outstanding

Contact & Details

Contact

Registered Address

2 Leman Street London E1W 9US United Kingdom

Website

www.example.com

Full company profile for QINECSA SOLUTIONS UK OPCO LIMITED (13916274), an active life sciences and medical technology company based in London, United Kingdom. Incorporated 15 Feb 2022. Activities of financial services holding companies. View financials, directors, shareholders, and filings.

Business Summary

This company specializes in providing innovative solutions and services across multiple sectors.

Products & Services

consulting software analytics integration

Reports

Credit Report

In-depth credit score, financial analysis, risk assessment and company intelligence.

Financials

Financials

Period 1 Jan → 31 Dec 2024
Type audit-exemption-subsidiary
Next accounts 29 Dec 2024
Due by 29 Dec 2025 6 months overdue

Net Assets, Total Assets & Total Liabilities (2022–2024)

Cash in Bank

£71.94k

Decreased by £195.75k (-73%)

Net Assets

-£33.50M

Decreased by £28.60M (-584%)

Total Liabilities

£34.42M

Increased by £24.61M (+251%)

Turnover

N/A

Employees

21

Increased by 11 (+110%)

Debt Ratio

3764%

Increased by 3564 (+1782%)

Financial History

Revenue, profit, EBITDA and key financial figures

2024
31 Dec Year End
2023
31 Dec Year End
P&L
Revenue
£142.3M
£128.7M
Gross Profit
£48.2M
£43.1M
Operating Profit
£22.4M
£19.8M
Net Profit
£18.1M
£15.9M
EBITDA
£31.5M
£28.2M
Assets
Cash
£24.7M
£21.3M
Total Assets
£89.4M
£82.1M
Liabilities
Total Liabilities
£45.2M
£41.8M
Key Metrics
Employees
1,247
1,156
Latest Revenue
£142.3M
Latest EBITDA
£31.5M
Cash Position
£24.7M

Funding

Fundraising & Grants

No fundraising or grants recorded

Investors (0)

No investor information available

Share Capital

Share Capital

Share allotments and capital structure

2 Allotments 5,660,332,488 Shares £56.60m Total
Date FromShare ClassShares AllottedAmount RaisedPrice/Share
21 Mar 20241,265,192,322$12.65m$0.01
31 Mar 20224,395,140,166$43.95m$0.01

Officers

Officers

0 active 3 resigned
Status

No officers found

No officers found

Shareholders

Shareholders (1)

Qinecsa Solutions Group Limited
100.0%
5,660,332,588

Persons with Significant Control

Persons with Significant Control (1)

1 Active
Active
Notified 15 Feb 2022
Nature of Control
  • Ownership Of Shares 75 To 100 Percent,voting Rights 75 To 100 Percent,right To Appoint And Remove Directors

Group Structure

Group Structure

QINECSA SOLUTIONS UK OPCO LIMITED Current Company
MYMEDSANDME LIMITED united kingdom

Charges

Charges

4 outstanding

Properties

Properties

0 total

No related properties

Documents

Company Filings

DateCategoryDescriptionDocument
20 Mar 2026AccountsAnnual accounts made up to 31 Dec 2024
16 Mar 2026Confirmation StatementConfirmation statement made on 15 Feb 2026 with updates
12 Mar 2026OfficersChange to director Mr Kevin John Budge on 12 Mar 2026
12 Mar 2026OfficersChange to director Mr Adam Sherlock on 12 Mar 2026
9 Mar 2026OtherAudit exemption statement of guarantee by parent company for period ending 31/12/24
20 Mar 2026 Accounts

Annual accounts made up to 31 Dec 2024

16 Mar 2026 Confirmation Statement

Confirmation statement made on 15 Feb 2026 with updates

12 Mar 2026 Officers

Change to director Mr Kevin John Budge on 12 Mar 2026

12 Mar 2026 Officers

Change to director Mr Adam Sherlock on 12 Mar 2026

9 Mar 2026 Other

Audit exemption statement of guarantee by parent company for period ending 31/12/24

Recent Activity

Latest Activity

Annual accounts made up to 31 Dec 2024

2 months ago on 20 Mar 2026

Confirmation statement made on 15 Feb 2026 with updates

2 months ago on 16 Mar 2026

Change to director Mr Kevin John Budge on 12 Mar 2026

3 months ago on 12 Mar 2026

Change to director Mr Adam Sherlock on 12 Mar 2026

3 months ago on 12 Mar 2026

Audit exemption statement of guarantee by parent company for period ending 31/12/24

3 months ago on 9 Mar 2026